| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5655201 | Diabetes & Metabolism | 2017 | 10 Pages |
Abstract
Smaller decreases in FHG were associated with not reaching the target HbA1c, suggesting a need to increase basal or premixed insulin doses to achieve targeted fasting plasma glucose and improve patient response before introducing more intensive prandial insulin regimens.
Keywords
EASDGLP-1FHGPHGFPGFasting hyperglycaemiaHbA1cOral antidiabetic medicationOAMAUCEuropean Association for the Study of DiabetesAmerican Diabetes Associationbasal insulinPremixed insulinType 2 diabetesFasting plasma glucosearea under the curveglycated haemoglobinPostprandial hyperglycaemiaADAglucagon-like peptide-1
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
A.J. Scheen, H. Schmitt, H.H. Jiang, T. Ivanyi,